These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8517875)

  • 1. Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors.
    Arthur JM; Casañas SJ; Raymond JR
    Biochem Pharmacol; 1993 Jun; 45(11):2337-41. PubMed ID: 8517875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X; Ennis C; Minchin MC
    Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level stable expression of recombinant 5-HT1A 5-hydroxytryptamine receptors in Chinese hamster ovary cells.
    Newman-Tancredi A; Wootton R; Strange PG
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):933-8. PubMed ID: 1386736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
    Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
    Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Rabin RA; Winter JC
    Eur J Pharmacol; 1993 Apr; 235(2-3):237-43. PubMed ID: 8508905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
    Wainscott DB; Sasso DA; Kursar JD; Baez M; Lucaites VL; Nelson DL
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):17-24. PubMed ID: 9459568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
    Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and modulation of 5-hydroxytryptamine1A receptors in P11 cells.
    Hensler JG; Cervera LS; Miller HA; Corbitt J
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1138-45. PubMed ID: 8819496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of 5-HT1A receptors in the goldfish retina: role of cyclic AMP in the regulation of the in vitro outgrowth of retinal explants.
    Schmeer C; Obregón F; Urbina M; Lima L
    Neurochem Res; 2001 Mar; 26(3):213-23. PubMed ID: 11495544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination.
    Winter JC; Rabin RA
    J Pharmacol Exp Ther; 1992 Nov; 263(2):682-9. PubMed ID: 1359109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterisation of the 5-HT1A serotonin receptor using the agonist [3H]8-OH-DPAT, and the antagonist [3H]spiperone.
    Sundaram H; Newman-Tancredi A; Strange PG
    Biochem Soc Trans; 1992 May; 20(2):145S. PubMed ID: 1397539
    [No Abstract]   [Full Text] [Related]  

  • 17. [3H]rauwolscine behaves as an agonist for the 5-HT1A receptors in human frontal cortex membranes.
    De Vos H; Czerwiec E; De Backer JP; De Potter W; Vauquelin G
    Eur J Pharmacol; 1991 May; 207(1):1-8. PubMed ID: 1680719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype.
    Perren MJ; Feniuk W; Humphrey PP
    Br J Pharmacol; 1991 Jan; 102(1):191-7. PubMed ID: 1675143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
    Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist.
    Jerning E; Svantesson GT; Mohell N
    Eur J Pharmacol; 1998 Nov; 360(2-3):219-25. PubMed ID: 9851589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.